- $107.98bn
- $166.92bn
- $61.22bn
- 71
- 50
- 63
- 63
2019 November 3rd | 2020 November 1st | 2021 October 31st | 2022 October 30th | 2023 October 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 39,281 | 35,540 | 43,932 | 52,179 | 61,218 |
Cost of Revenue | |||||
Gross Profit | 12,069 | 11,630 | 14,371 | 16,541 | 22,967 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 33,783 | 30,386 | 35,429 | 42,256 | 45,657 |
Operating Profit | 5,498 | 5,154 | 8,503 | 9,923 | 15,561 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 4,088 | 3,883 | 7,602 | 9,127 | 13,019 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,168 | 2,801 | 5,944 | 7,120 | 10,148 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,253 | 2,751 | 5,963 | 7,131 | 10,166 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,253 | 2,751 | 5,963 | 7,131 | 10,166 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.1 | 10 | 18.7 | 23.6 | 34.6 |
Dividends per Share |